The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

Charlton R. A.; Bettoli V.; Bos H. J.; Engeland A.; Garne E.; Gini R.; Hansen A. V.; de Jong-van den Berg L. T. W.; Jordan S.; Klungsoyr K.; Neville A. J.; Pierini A.; Puccini A.; Sinclair M.; Thayer D.; Dolk H.

首页> 外文期刊>European journal of clinical pharmacology >The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

【24h】

The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

机译：一些欧洲医疗保健数据库监测妊娠预防计划的有效性作为风险最小化措施的局限性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Pregnancy prevention programmes (PPPs) exist for some medicines known to be highly teratogenic. It is increasingly recognised that the impact of these risk minimisation measures requires periodic evaluation. This study aimed to assess the extent to which some of the data needed to monitor the effectiveness of PPPs may be present in European healthcare databases.

机译：存在妊娠预防计划（PPP）对于已知高度致畸的药物存在。越来越认识到，这些风险最小化措施的影响需要定期评估。本研究旨在评估监测PPP所需的一些数据的程度，可能存在于欧洲医疗数据库中。

著录项

来源
《European journal of clinical pharmacology》 |2018年第4期|共8页
作者
Charlton R. A.; Bettoli V.; Bos H. J.; Engeland A.; Garne E.; Gini R.; Hansen A. V.; de Jong-van den Berg L. T. W.; Jordan S.; Klungsoyr K.; Neville A. J.; Pierini A.; Puccini A.; Sinclair M.; Thayer D.; Dolk H.;
展开▼
作者单位

Univ Bath Dept Pharm &

Pharmacol Bath BA2 7AY Avon England;

Univ Ferrara Dermatol Sect Dept Clin &

Expt Med Ferrara Italy;

Univ Groningen Dept Pharm Pharmacoepidemiol &

Pharmacoecon Unit Groningen Netherlands;

Norwegian Inst Publ Hlth Dept Pharmacoepidemiol Oslo Norway;

Hosp Lillebaelt Dept Paediat Kolding Denmark;

Agenzia Reg Sanita Toscana Florence Italy;

Univ Copenhagen Dept Publ Hlth Copenhagen Denmark;

Univ Groningen Dept Pharm Pharmacoepidemiol &

Pharmacoecon Unit Groningen Netherlands;

Swansea Univ Dept Nursing Coll Human &

Hlth Sci Swansea W Glam Wales;

Univ Bergen Dept Global Publ Hlth &

Primary Care Bergen Norway;

Univ Ferrara Ctr Clin &

Epidemiol Res IMER Emilia Romagna Registry Birth Defects Ferrara Italy;

Fdn Toscana Gabriele Monasterio Natl Res Council IFC CNR Inst Clin Physiol Pisa Italy;

Emilia Romagna Reg Hlth Author Drug Policy Serv Bologna Italy;

Univ Ulster Inst Nursing &

Hlth Res Newtownabbey North Ireland;

Swansea Univ Sch Med Swansea W Glam Wales;

Univ Ulster Inst Nursing &

Hlth Res Newtownabbey North Ireland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Pregnancy; Teratogen; Pregnancy prevention programme; Electronic health records; Isotretinoin;

机译：妊娠;致畸;怀孕预防计划;电子健康记录;isotretinoin;
入库时间 2022-08-20 02:48:21

相似文献

外文文献
中文文献
专利

1. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures [J] . Charlton R. A., Bettoli V., Bos H. J., European journal of clinical pharmacology . 2018,第4期

机译：一些欧洲医疗保健数据库监测妊娠预防计划的有效性作为风险最小化措施的局限性
2. A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies [J] . Vora Pareen, Artime Esther, Soriano‐Gabarró Montse, Pharmacoepidemiology and drug safety . 2018,第7期

机译：利用欧盟电子局局局局局委员会电子注册评估欧洲风险最小化措施有效性的研究
3. Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation Measures [J] . Emmanuelle Jacquot, Estelle Collin, Amy Ladner, Pharmaceutical medicine . 2019,第4期

机译：选定的欧洲国家的胍葡萄酒药物利用研究：评估风险最小化措施有效性的跨国公司，观测研究
4. Investigation of the Effectiveness of European Assembly Worksheet in Assessing Organizational Measures for MSD Risk Assessment [C] . Tobias Hellig, Vera Rick, Robert Stranzenbach, International Conference on Applied Human Factors and Ergonomics . 2018

机译：欧洲大会工作表效能调查在评估MSD风险评估的组织措施中
5. Improving global monitoring of vaccine safety: An evaluation of the World Health Organization Programme for International Drug Monitoring and Adverse Reactions Database on how they serve the needs of vaccine safety. [D] . Letourneau, Megan A. 2007

机译：改进疫苗安全性的全球监测：对世界卫生组织国际药物监测和不良反应数据库计划的评估，说明它们如何满足疫苗安全性需求。
6. A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies [O] . Pareen Vora, Esther Artime, Montse Soriano‐Gabarró, -1

机译：使用欧洲联盟授权后研究电子注册评估欧洲风险最小化措施有效性的研究综述
7. Drug related safety issues affecting pregnancy outcome and concerning risk minimisation measures : emphasis on pregnancy prevention programmes [O] . Crijns Hubertina Johanna Maria Josephina 2012

机译：与药物有关的安全问题，影响妊娠结局并涉及风险最小化措施：重点在于预防妊娠方案
8. Teen Pregnancy: State and Federal Efforts to Implement Prevention Programs and211 Measure Their Effectiveness [R] . 1998

机译：青少年怀孕：州和联邦政府实施预防计划和211衡量其有效性

The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

摘要

著录项

相似文献

相关主题

期刊订阅